First Trust Advisors’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.27M Buy
+56,051
New +$1.4M ﹤0.01% 2155
2025
Q3
Sell
-11,378
Closed -$655K 2707
2025
Q2
$655K Sell
11,378
-50,064
-81% -$2.83M ﹤0.01% 2188
2025
Q1
$3.58M Sell
61,442
-49,540
-45% -$3.38M ﹤0.01% 1497
2024
Q4
$8.94M Sell
110,982
-915
-0.8% -$78.2K 0.01% 1099
2024
Q3
$8.97M Buy
111,897
+560
+0.5% +$39.8K 0.01% 1079
2024
Q2
$6.8M Buy
111,337
+33,051
+42% +$1.97M 0.01% 1140
2024
Q1
$3.87M Buy
78,286
+19,369
+33% +$922K ﹤0.01% 1426
2023
Q4
$2.47M Buy
58,917
+9,380
+19% +$319K ﹤0.01% 1627
2023
Q3
$1.63M Buy
+49,537
New +$1.69M ﹤0.01% 1768
2023
Q2
Sell
-76,923
Closed -$2.18M 2427
2023
Q1
$2.18M Sell
76,923
-87,391
-53% -$3.08M ﹤0.01% 1653
2022
Q4
$6.83M Buy
164,314
+88,141
+116% +$3.78M 0.01% 1076
2022
Q3
$3.16M Buy
76,173
+21,326
+39% +$851K ﹤0.01% 1427
2022
Q2
$1.79M Buy
+54,847
New +$2M ﹤0.01% 1768

Other funds holding PRCT

First Trust Advisors's PRCT Position: Q2 2026 in Review

First Trust Advisors opened a new position in Procept Biorobotics (PRCT) in Q2 2026: 56,051 shares worth $1.27M. The stake represents ﹤0.01% of the portfolio and ranks #2155 among its holdings. This is a return to the name: First Trust Advisors previously reported a position in PRCT as recently as Q2 2025.

First Trust Advisors first reported a position in PRCT in Q2 2022 and has held it in 13 quarters since. The position peaked at $8.97M in Q3 2024. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • First Trust Advisors held 56,051 shares of Procept Biorobotics worth $1.27M as of Q2 2026.
  • Procept Biorobotics was a new First Trust Advisors position in Q2 2026.
  • Procept Biorobotics made up ﹤0.01% of First Trust Advisors's portfolio in Q2 2026, its #2155 holding.
  • First Trust Advisors first reported a position in Procept Biorobotics in Q2 2022 and has held it in 13 quarters since.
  • First Trust Advisors's Procept Biorobotics position peaked at $8.97M in Q3 2024.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on First Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.